Abstract: The present invention provides a method of attenuating the formation or reducing the severity of neurogenic swelling and/or neurogenic inflammation in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of neurogenic swelling and/or neurogenic inflammation.

Abstract: A method of stabilizing a multiphase composition is described. The composition comprises a structured surfactant phase, a benefit phase and a perfume comprising perfume raw materials. The method comprises a step of selecting at least 70% of the perfume raw materials that have a ClogP of greater than 1.8.

Abstract: The present invention provides a method for treating symptoms of diabetes in a diabetic subject which comprises administering to the subject a therapeutically effective amount of an agent which inhibits binding of advanced glycation endproducts to any receptor for advanced glycation endproducts so as to treat chronic symptoms of diabetes in the subject.

Abstract: Oral compositions comprising silicone polyols are described for lubricating and hydrating the buccal cavity and are of benefit in alleviating the symptoms of xerostomia (dry mouth).

Abstract: Silicone-free, carbon-based replacements for volatile silicones, such as cyclomethicones, are disclosed. The compositions can be used as is or in dermatological products.

Abstract: Compositions for preventing and/or treating sensitive and/or dry skin include at least an effective amount of at least one agent and at least an effective amount of at least one divalent inorganic cation, wherein the at least one agent includes at least one member selected from the group consisting of at least one microorganism, a fraction of the at least one microorganism and a metabolite of the at least one microorganism. Methods for preparing such compositions and cosmetic treatment methods employing such compositions are also provided.

Abstract: Novel (co)polymeric structures having functional groups making possible, under conditions that are safe for human use, the formation of chemical bonds with human keratin, and in particular with the keratin present in hair, eyelashes and eyebrows, skin, nails, lips, the oral mucosa and tissues of the external genital organs are disclosed; the invention also relates to the synthesis of such (co)polymeric structures and the use thereof in the fields of cosmetics and medicine.

Abstract: A color cosmetic composition containing at least one ester of rosin acid, polyglyceryl-2 isostearate/dimer dilinoleate copolymer, and pigments or colorants.

Abstract: Bi- or multiphasic, clear or translucent silicone-containing lubricant compositions, condom products including such compositions and methods of making such compositions and condom products are disclosed. The refractive index of each immiscible phase of the lubricant composition is matched to that of each other phase to make the composition clear or translucent. The compositions are highly lubricious, non-staining, and easily washable.

Abstract: The present invention relates to a linear ethylenic block copolymer comprising in each block at least one ionic hydrophilic unit, which may be different from one block to another, the said ionic hydrophilic unit being present in each block in a proportion of from 2% to 100% by weight relative to the weight of the said block. The invention also relates to a cosmetic or pharmaceutical composition comprising such a copolymer, and also to a cosmetic process for making up or caring for keratin materials using the said composition.

Abstract: This invention relates to personal care compositions containing polytrimethylene ether glycol in a variety of physical forms including solutions, gels, oil-in-water emulsions, water-in-oil emulsions, suspensions and solids. In a particularly preferred embodiment, the polytrimethylene ether glycol is derived predominantly from monomers obtained from renewable resources, making the personal care products of this embodiment of the present invention more environmentally friendly in terms of their manufacture, use and disposal.

Abstract: A cosmetic composition containing: (a) at least one tackifier component having a solubility parameter corresponding to ?; (b) at least one liposoluble polymer having at least one segment with a solubility parameter corresponding to ?+2; (c) at least one solvent; and (d) optionally, at least one colorant.

Abstract: The present invention provides a method of attenuating the formation or reducing the severity of a neurogenic bruise in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of bruising.

Abstract: The invention relates to the synthesis of siloxane polymers containing self-complementary quadruple hydrogen bonding groups (4H-units). The resulting polymers show unique new characteristics that result from the reversible, physical interactions between the polysiloxane chains that are based on the (supramolecular) interactions between the 4H-units. The polysiloxanes in this invention show unprecedented bulk material properties and are used as gelling agents for silicone fluids. The resulting gels are clear and display good material properties, while having unparalleled high silicone fluid contents.

Abstract: The invention relates in particular to a composition for topical application to the skin, comprising, in a physiologically acceptable medium, at least one peptide increasing the expression of mechanoreceptors in the cells of the skin and at least one tensing agent. According to one alternative the agent increasing the expression of mechanoreceptors in the cells of the skin is selected from zinc salts, copper salts, manganese salts, derivatives thereof and mixtures thereof. The invention likewise relates to a skincare kit comprising at least two compositions comprising respectively the tensing agent and the agent increasing the expression of mechanoreceptors in the cells of the skin. The invention also relates to a method of cosmetic treatment of the skin that comprises simultaneous or sequential application of said compositions.

Abstract: Ophthalmic compositions suitable for use as artificial tears or as vehicles for ophthalmic drugs are disclosed. The compositions contain a combination of three polymers that have a synergistic effect on viscosity.

Abstract: In the prior cosmetics, the cosmetic product provided with sufficient storage stability together with excellent usability can not be realized, and it has been an actual state that a cosmetic product having sense of non-tackiness etc. and excellent usability has poor storage stability. The present invention provides a cosmetic for providing a cosmetic product having more excellent usability and storage stability as a cosmetic, and a method for making the same. The cosmetic of the present invention is characterized by comprising an amino acid oil gelling agent and a polyamide resin, thereby a cosmetic product having excellent usability and sufficient storage stability in combination can be realized.

Abstract: In a prior cosmetic, a cosmetic product provided with sufficient storage stability together with excellent usability can not be realized, and it has been an actual state that a cosmetic product having sense of non-tackiness etc. and excellent usability has poor storage stability. In the present invention, as a cosmetic, a cosmetic for producing a cosmetic product having more excellent usability and storage stability, and a method for making the same, are provided. The cosmetic of the present invention is characterized in that it comprises an amino acid oil gelling agent, a polyamide resin and one or more monoesters selected from a monoester having a C9 to C24 linear chain or branched chain fatty acid residue and/or a C9 to C24 linear chain or branched chain alcohol residue, and thereby, a cosmetic product having excellent usability and sufficient storage stability in combination can be realized.

Abstract: Use of a polylysine, polyamidoamine or polypropylenimine dendrimer having naphthyl disulphonate terminal groups as a topically applied agent in prophylaxis or treatment of sexually transmitted diseases.

Abstract: The present application relates to a cosmetic composition in cast form, in a pot or as a stick, comprising at least one polyester that can be obtained by reaction: of at least one polyol comprising 3 to 6 hydroxyl groups; of at least one non-aromatic monocarboxylic acid; of at least one aromatic monocarboxylic acid, and of at least one polycarboxylic acid comprising at least 2 carboxyl groups COOH and/or a cyclic anhydride of such a polycarboxylic acid. The application also relates to a method of cosmetic treatment using said composition, as well as the use of this composition for the care or the make-up of the skin or of the lips.

Abstract: Dispersions of particles of surface-stabilized polymer, in a nonaqueous medium, in which the polymer contains 5% to 50% by weight of ethylenic monomers which can contain a PEG (polyethylene glycol) part. Dispersions can be used in cosmetic or pharmaceutical compositions such as lipstick or hair. The composition can be used to treat keratin materials.

Abstract: The invention relates to a compound which is an ester of 1,2,3-propanetriol with one or more C11 to C24 fatty acids, wherein at least one fatty acid has at least one double bond. The compound is useful in the treatment of chronic inflammatory disorders.

Abstract: A cosmetic or dermatological preparation for combating or substantially preventing pollen allergies. The preparation comprises or essentially consists of a lipid phase which comprises one or more lipids and has a spreading coefficient of less than about 800 mm2/10 min at 25° C. and a viscosity of from about 40 to about 25,000 mPas. This Abstract is not intended to define the invention disclosed in the specification, nor intended to limit the scope of the invention in any way.

Abstract: A hydroalcoholic lotion is disclosed which comprises (a) a lower alcohol and water in a weight ratio of about 35:65 to 100:0, and (b) between at least 0.5% and 8% by weight thickener system comprised of at least one emulsifier present in at least 0.05% by weight wherein the composition in a polymer free state has a viscosity of at least 4,000 centipoise at 23 degrees C. and wherein the emulsifier is comprised of at least one hydrophobic group and at least one hydrophilic group. The hydroalcoholic composition is useful as a hand preparation such as a lotion or as a presurgical scrub replacement.

Abstract: This invention relates to personal lubricant compositions that are relatively non-tacky while maintaining lubricity.

Abstract: A method of making an oil-in-water emulsion is described in which an oil emulsifier and a polysaccharide emulsion stabiliser, which stabiliser comprises a Xanthan polysaccharide and a polyglucomannan polysaccharide, is dispersed in an oil. The oil-based dispersion so formed is then combined with water, preferably at low temperature and under low shear conditions, to form an oil-in-water emulsion. The polysaccharide emulsion stabiliser and optionally oil emulsifier may be dispersed directly into a relatively polar oil to form the oil-based dispersion or, alternatively, into a relatively polar non-aqueous liquid medium, which medium then being mixed with the oil before it is combined with the water to form the emulsion. The oil-in-water emulsions are particularly useful in personal care and cosmetic applications such as sprays, body moisturisers, sun screens and wet wipes for cosmetic or personal hygiene cleaning uses.

Abstract: The present invention relates to compositions comprising a structured benefit agent pre-mix or delivery vehicle comprising benefit agent structured with crystalline materials, as defined, which when separately prepared and combined after preparation, provides enhanced deposition of hydrophilic benefit agents carried on, trapped within or in the presence of the structured benefit agent.

Abstract: Method and device to create energized polymers that can be used for pain relief, comprised of an ultrasound system that ultrasonically energize polymers that can then be used to provide an analgesic effect. Ultrasound waves are delivered to a polymer through direct contact, through a coupling medium, or without contact in order to energize the polymer. Other energies such as such as UV, microwave, laser, electricity, RF, sun, light, magnetic/electromagnetic, et can also be used to energize the polymer. The energized polymer can be immediately placed on a user to provide an analgesic effect, or the energized polymer can be placed storage material and removed at a later time to be placed on a user to provide an analgesic effect.

Abstract: The present invention discloses compositions derived from an isolated Bacillus species spores, or an extracellular product of Bacillus coagulans comprising a supernatant or filtrate of a culture of said Bacillus coagulans strain, suitable for topical application to the skin or mucosal membranes of a mammal, which are utilized to inhibit the growth of bacterium, yeast, fungi, virus, and combinations thereof. The present invention also discloses methods of treatment and therapeutic systems for inhibiting the growth of bacterium, yeast, fungi, virus, and combinations thereof, by topical application of therapeutic compositions which are comprised, in part, of isolated Bacillus species, spores, or an extracellular product of Bacillus coagulans comprising a supernatant or filtrate of a culture of said Bacillus coagulans strain.

Abstract: A pigment dispersed in a silicone polymer is combined with at least one cosmetic component or at least one dematologically acceptable and active agent to prepare a wide variety of cosmetic and personal care compositions. The pigment may be dispersed in a polysiloxane, such as an alkylpolysiloxane, to provide a pigment dispersion that is easily blended with cosmetically acceptable components or dematologically active agents to provide a pigmented cosmetic or personal care composition.

Abstract: The present invention discloses compositions derived from an isolated Bacillus species, spores, or an extracellular product of Bacillus coagulans comprising a supernatant or filtrate of a culture of said Bacillus coagulans strain, suitable for topical application to the skin or mucosal membranes of a mammal, which are utilized to inhibit the growth of bacterium, yeast, fungi, virus, and combinations thereof. The present invention also discloses methods of treatment and therapeutic systems for inhibiting the growth of bacterium, yeast, fungi, virus, and combinations thereof, by topical application of therapeutic compositions which are comprised, in part, of isolated Bacillus species, spores, or an extracellular product of Bacillus coagulans comprising a supernatant or filtrate of a culture of said Bacillus coagulans strain.

Abstract: Topical compositions having as the active ingredient a hydrophilic material, such as a polyalkylene oxide homopolymer or copolymer, and methods of use, have been developed for the amelioration or prevention of pain or the sequelae of pain. The composition may be in the form of a cream, gel, lotion, spray, foam, paste, patch, suspension or dispersion. In the preferred embodiment, the formulation is a gel. The composition may contain a penetration enhancer, most preferably one with membrane disruptive properties. In one embodiment, the compositions are incorporated onto or into disposables such as hemorrhoid wipes, gauze, sponge, bandages, and wraps; mouth guards, dental trays; needles or catheters; adult diapers; gloves, socks or wrist bands, for ease of application. The composition is applied topically to a site at or adjacent to a painful region. The composition is reapplied as necessary.

Abstract: A topical cosmetic or dermatological preparation which is effective for treating a pruritic condition, is present as a non-ionic O/W emulsion, and comprises water, one or more oil phases, PEG 12 cetearylether and/or PEG 40 monostearate, polidocanol, menthol, and one or more O/W emulsifiers or co-emulsifiers.

Abstract: A cooling composition for application to the skin of a mammal, such as a human. The base of the composition is an interpenetrating polymer network, which may contain a thermo-responsive polymer. Having a Critical Temperature above an average core body temperature, the material may undergo a phase change as the creature becomes too warm, such as when a person experiences a hot flash, a fever, exposure to very warm environments, physical exertion, and the like. The phase change results in a cooling and/or cooling sensation of the skin. Additives may be included in the cooling composition such as evaporative cooling components, neurosensory cooling components, and additional phase change components.

Abstract: The invention provides a cosmetic or pharmaceutical composition comprising, in a physiologically acceptable medium, at least one purified natural or synthetic polypeptide wherein the peptide sequence is represented wholly or partly by at least one sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 16, SEQ ID NO: 25 and SEQ ID NO: 27 and their homologs.

Abstract: A method of controlling oil-absorbing properties of a silicone rubber powder characterized by keeping a silicone rubber powder in hot storage at a temperature in the range of 40° C. to 150° C. or in cold storage at a temperature in the range of 0° C. to 10° C.

Abstract: An olefin wax (A) is (i) a copolymer (A1) obtained by copolymerizing ethylene and at least one diene or a copolymer (A2) obtained by copolymerizing ethylene, at least one olefin selected from ?-olefins of 3 to 12 carbon atoms and at least one diene; wherein (ii) the content of unsaturated groups per one molecule is in the range of 0.5 to 3.0 groups; (iii) the density is in the range of 870 to 980 kg/m3; (iv) the melting point is in the range of 70 to 130° C.; (v) the number-average molecular weight is in the range of 400 to 5,000; and (vi) the ratio (Mw/Mn) of the weight-average molecular weight to the number-average molecular weight is not more than 4.0. A silicone-modified olefin wax can be obtained by reacting hydrogen silicone with the olefin wax (A). Cosmetics contain the silicone-modified olefin wax.

Abstract: The disclosure relates to novel cosmetic compositions comprising, in a cosmetically acceptable medium: (i) at least one cationic polymer which is obtained by polymerization of a mixture of monomers comprising: a) at least one vinyl monomer substituted with at least one amino group, b) at least one hydrophobic nonionic vinyl monomer, chosen from those of formulae (I) and (II): CH2?C(X)Z,??(I) CH2?CH—OC(O)R;??(II) wherein X, Z, and R are defined in the present specification; c) at least one associative vinyl monomer, and d) at least one hydroxylated nonionic vinyl monomer; and (ii) at least one starch. These compositions may have a texture which does not change over time and which may allow a better distribution, better lathering properties and also better cosmetic properties.

Abstract: The present invention relates to the use of imidazolium alkyl(meth)acrylate homo- and copolymers in cosmetic preparations and to the corresponding cosmetic preparations.

Abstract: This invention relates to substantially anhydrous warming, non-toxic and nonirritating lubricating compositions containing polyols and preferably an insulating agent. The invention also relates to methods of using such compositions for lubrication, administration of active ingredients and for preventing or treating dysmenorrhea.

Abstract: The invention relates to a process for dissolving at least one compound of low solubility in water, the said process comprising the essential step of mixing the compound of low solubility with at least one lipophilic amino acid derivative. The invention also relates to a cosmetic or dermatological composition comprising, in a physiologically acceptable medium, at least one compound of low solubility and at least one lipophilic amino acid derivative. Among the compounds of low solubility that are especially included are aminophenol derivatives, salicylic acid derivatives, 2-amino-4-alkylaminopyrimidine 3-oxide derivatives and DHEA, and also its chemical or metabolic derivatives and precursors.

Abstract: A moisture-curable and biodegradable adhesive that includes the reaction product of: (a) an isocyanate component having an average functionality of at least 2; (b) an active hydrogen component having an average functionality greater than 2.1; and (c) an ionic salt component having an average hydroxyl or amino functionality, or combination thereof, of at least 1.

Abstract: A personal lubricant composition comprises a mixture of a latent lubricant additive and a carrier lubricant, in which the latent lubricant additive is insoluble in the carrier lubricant but is capable of activation on contact with body fluids to realise lubricant properties. The additive may comprise a poly(ethylene oxide) polymer and the carrier lubricant may comprise glycols such as glycerol and propylene glycol or mixtures thereof.

Abstract: A composition for topical application, in the form of an oil-in-water emulsion, containing at least one nonionic emulsifier with a melting point of less than 45°C. and at least one 2-acrylamido-2-methylpropanesulfonic acid polymer. The composition shows very good stability.

Abstract: To provide a skin cleanser having superior lather quality at cleansing and improved moist and soft feeling after cleansing. A skin cleansing composition comprising an amphoteric terpolymer which consists of, 5 to 15 mass % of an anionic monomer (ex. acrylic acid), 15 to 40 mass % of a cationic monomer (ex. dimethyldiallylammonium chloride) and 45 to 80 mass % of a nonionic monomer (ex. acrylamide).

Abstract: The present invention relates to a solid composition containing, in a physiologically acceptable medium, at least one fatty phase containing: at least one resin with a number-average molecular weight of less than or equal to 10 000 g/mol, chosen from rosin, rosin derivatives and hydrocarbon-based resins, and at least one silicone polyamide, the silicone polyamide containing at least one silicone portion with a mean degree of polymerization of greater than or equal to 50 and representing at least 10% of the total weight of the composition.

Abstract: The invention relates to self-stabilized dispersions of polymer particles in a non-aqueous non-silicone medium, and to a process for preparing the said polymers. The invention also relates to cosmetic or pharmaceutical compositions comprising the said polymer particle dispersions.

Abstract: It is an object of our invention to provide capsule particles and a method of creating larger and robust capsule particles that will have excellent storage stability and enhanced perfumer performance in a range of consumer products.

Abstract: Staple Stable, aqueous gel vehicles are provided for the topical application to the skin of irritating active ingredients such as retinoids, particularly tretinoin, with slow release of the active ingredient and minimal irritancy to the skin. The vehicles include a gelling agent effective to form a gel and hold the active ingredient in the aqueous medium for slow release on the skin, and an effective amount of an antioxidant to retard decomposition of the active ingredient. The vehicles and formulations are preferably aqueous emulsions which contain a solubilizing agent for the generally non-water soluble active ingredients, as well as usually an emulsifying agent and/or surfactant. Chelating agents, emollients, preservatives and other adjuvants and additives may also be included in the vehicles and formulations.

Abstract: The mastitis control teat dip composition having a visible indicator aspect of the invention provides a softening, soothing, smoothing, relaxing property, a rapid initial kill, a useful highly pseudoplastic rheology, a barrier/film-forming capacity, a unique antimicrobial composition that is stable over an extended period of time, and unexpected long term microbial control when compared to the prior art materials disclosed in patents and used in the marketplace. The indicator aspect provides ease of visually detecting the material on the animal skin and can indicate efficacy of the material. The compositions of the invention are made by combining an aqueous liquid composition containing the visual indicator combined with the organic components which can be combined with a simple aqueous solution of a salt of chlorous acid, preferably an alkali metal chlorite.